Literature DB >> 19369349

Vaccinia virus E3 suppresses expression of diverse cytokines through inhibition of the PKR, NF-kappaB, and IRF3 pathways.

Chad Myskiw1, Janilyn Arsenio, Rebekah van Bruggen, Yvon Deschambault, Jingxin Cao.   

Abstract

The vaccinia virus double-stranded RNA binding protein E3 has been demonstrated to inhibit the expression of cytokines, including beta interferon (IFN-beta) and tumor necrosis factor alpha (TNF-alpha). However, few details regarding the molecular mechanisms of this inhibition have been described. Using real-time PCR arrays, we found that E3 suppressed the induction of a diverse array of cytokines representing members of the IFN, interleukin (IL), TNF, and transforming growth factor cytokine families. We discovered that the factor(s) responsible for the induction of IL-6, TNF-alpha, and inhibin beta A (INHBA) was associated with the early and late phases of virus infection. In contrast, the factor(s) which regulates IFN-beta induction was associated with the late phase of replication. We have found that expression of these cytokines can be induced by transfection of cells with RNA isolated from vaccinia virus-infected cells. Moreover, we provide evidence that E3 antagonizes both PKR-dependent and PKR-independent pathways to regulate cytokine expression. PKR-dependent activation of p38 and NF-kappaB was required for vaccinia virus-induced INHBA expression, whereas induction of TNF-alpha required only PKR-dependent NF-kappaB activation. In contrast, induction of IL-6 and IFN-beta was largely PKR independent. IL-6 induction is regulated by NF-kappaB, while IFN-beta induction is mediated by IFN-beta promoter stimulator 1 and IFN regulatory factor 3/NF-kappaB. Collectively, these results indicate that E3 suppresses distinct but interlinked host signaling pathways to inhibit the expression of a diverse array of cytokines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19369349      PMCID: PMC2698532          DOI: 10.1128/JVI.02570-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Suppression of proinflammatory signal transduction and gene expression by the dual nucleic acid binding domains of the vaccinia virus E3L proteins.

Authors:  Jeffrey O Langland; John C Kash; Victoria Carter; Matthew J Thomas; Michael G Katze; Bertram L Jacobs
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 2.  Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures.

Authors:  Richard E Randall; Stephen Goodbourn
Journal:  J Gen Virol       Date:  2008-01       Impact factor: 3.891

3.  The identification and characterization of a monoclonal antibody to the vaccinia virus E3 protein.

Authors:  Jessica R Weaver; Mohammad Shamim; Edward Alexander; D Huw Davies; Philip L Felgner; Stuart N Isaacs
Journal:  Virus Res       Date:  2007-06-20       Impact factor: 3.303

4.  Loss of protein kinase PKR expression in human HeLa cells complements the vaccinia virus E3L deletion mutant phenotype by restoration of viral protein synthesis.

Authors:  Ping Zhang; Bertram L Jacobs; Charles E Samuel
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

5.  The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways.

Authors:  Tiejun Zhao; Long Yang; Qiang Sun; Meztli Arguello; Dean W Ballard; John Hiscott; Rongtuan Lin
Journal:  Nat Immunol       Date:  2007-04-29       Impact factor: 25.606

6.  The vaccinia virus E3L gene product interacts with both the regulatory and the substrate binding regions of PKR: implications for PKR autoregulation.

Authors:  T V Sharp; F Moonan; A Romashko; B Joshi; G N Barber; R Jagus
Journal:  Virology       Date:  1998-10-25       Impact factor: 3.616

7.  MKK6 activates myocardial cell NF-kappaB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner.

Authors:  D Zechner; R Craig; D S Hanford; P M McDonough; R A Sabbadini; C C Glembotski
Journal:  J Biol Chem       Date:  1998-04-03       Impact factor: 5.157

8.  Expression of the E3L gene of vaccinia virus in transgenic mice decreases host resistance to vaccinia virus and Leishmania major infections.

Authors:  Elena Domingo-Gil; Eva Pérez-Jiménez; Iván Ventoso; José L Nájera; Mariano Esteban
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

9.  West Nile virus-induced interferon production is mediated by the double-stranded RNA-dependent protein kinase PKR.

Authors:  Felicia D Gilfoy; Peter W Mason
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

Review 10.  Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action.

Authors:  M A García; J Gil; I Ventoso; S Guerra; E Domingo; C Rivas; M Esteban
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

View more
  47 in total

1.  Viral double-stranded RNAs from vaccinia virus early or intermediate gene transcripts possess PKR activating function, resulting in NF-kappaB activation, when the K1 protein is absent or mutated.

Authors:  Kristen L Willis; Jeffrey O Langland; Joanna L Shisler
Journal:  J Biol Chem       Date:  2010-12-23       Impact factor: 5.157

2.  Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; V Shane Pankratz; Iana H Haralambieva; Robert A Vierkant; Gregory A Poland
Journal:  Hum Genet       Date:  2012-05-19       Impact factor: 4.132

3.  Identification of 10 cowpox virus proteins that are necessary for induction of hemorrhagic lesions (red pocks) on chorioallantoic membranes.

Authors:  Zhiyong Xu; Dimitrios Zikos; Aistė Tamošiūnaitė; Robert Klopfleisch; Nikolaus Osterrieder; B Karsten Tischer
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

4.  Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man.

Authors:  Juan C Zapata; Maria S Salvato
Journal:  Future Virol       Date:  2015-03-13       Impact factor: 1.831

5.  Poxviral protein E3-altered cytokine production reveals that DExD/H-box helicase 9 controls Toll-like receptor-stimulated immune responses.

Authors:  Alan Dempsey; Sinead E Keating; Michael Carty; Andrew G Bowie
Journal:  J Biol Chem       Date:  2018-08-15       Impact factor: 5.157

6.  Epstein-Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-beta.

Authors:  Gretchen L Bentz; Renshui Liu; Angela M Hahn; Julia Shackelford; Joseph S Pagano
Journal:  Virology       Date:  2010-04-08       Impact factor: 3.616

7.  Mutational analysis of vaccinia virus E3 protein: the biological functions do not correlate with its biochemical capacity to bind double-stranded RNA.

Authors:  Kevin J Dueck; YuanShen Sandy Hu; Peter Chen; Yvon Deschambault; Jocelyn Lee; Jessie Varga; Jingxin Cao
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

8.  Kinetics of serum cytokines after primary or repeat vaccination with the smallpox vaccine.

Authors:  Jeffrey I Cohen; Patricia Hohman; Rachael Fulton; Siu-Ping Turk; Jing Qin; Karen Thatcher; Ronald L Hornung
Journal:  J Infect Dis       Date:  2010-04-15       Impact factor: 5.226

9.  A novel inhibitor of the NF-{kappa}B signaling pathway encoded by the parapoxvirus orf virus.

Authors:  D G Diel; G Delhon; S Luo; E F Flores; D L Rock
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

10.  Comparative analysis of poxvirus orthologues of the vaccinia virus E3 protein: modulation of protein kinase R activity, cytokine responses, and virus pathogenicity.

Authors:  Chad Myskiw; Janilyn Arsenio; Craig Hammett; Rebekah van Bruggen; Yvon Deschambault; Nicole Beausoleil; Shawn Babiuk; Jingxin Cao
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.